Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"

Islam Y. Elgendy, Ahmed N. Mahmoud, Emmanouil S. Brilakis, Anthony A. Bavry

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)211-212
Number of pages2
JournalEuroIntervention
Volume15
Issue number2
DOIs
StatePublished - Jun 2019

Funding

E. Brilakis reports consulting/speaker honoraria from Abbott Vascular, Amgen, Asahi, CSI, Elsevier, GE Healthcare, and Medicure, research support from Boston Scientific and Osprey,

FundersFunder number
Boston Scientific and Osprey
Abbott Vascular

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"'. Together they form a unique fingerprint.

    Cite this